Drybench Patent.
Patent and exclusivity dates from July to December 2040 for NDAs, as FDA's Orange Book lists them
Each patent and exclusivity date from July to December 2040 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.
FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.
- Orange Book captured
- 14 October 2026
Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.
This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.
Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.
NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book
Listed dates, 2040January to June 2040
Listed patent expiry (143)
2 Jul 2040 · NDA 212099 · DAROLUTAMIDE
US 12,611,397, product patent
patent.txt line 13,542- Flags
- product
- Product numbers
- 001
6 Jul 2040 · NDA 208798 · FLUTICASONE PROPIONATE
US 11,173,259, product patent
patent.txt lines 9,480, 9,490, 9,500, 9,514- Flags
- product
- Product numbers
- 004, 005, 006, 008
6 Jul 2040 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US 11,173,259, product patent
patent.txt lines 9,544, 9,558, 9,570- Flags
- product
- Product numbers
- 004, 005, 006
6 Jul 2040 · NDA 211280 · LASMIDITAN SUCCINATE
US 12,071,423, product patent
patent.txt lines 12,664, 12,668- Flags
- product
- Product numbers
- 001, 002
7 Jul 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 12,090,155, product and use patent
patent.txt line 10,451- Flags
- product use code U-4000
- Product numbers
- 001
16 Jul 2040 · NDA 215239 · VAMOROLONE
US 11,382,922, substance and product patent
patent.txt line 16,591- Flags
- substance product
- Product numbers
- 001
17 Jul 2040 · NDA 215390 · DEXMEDETOMIDINE HYDROCHLORIDE
US 11,890,272, use patent
patent.txt lines 16,835, 16,850- Flags
- use code U-3756
- Product numbers
- 001, 002
17 Jul 2040 · NDA 215390 · DEXMEDETOMIDINE HYDROCHLORIDE
US 11,890,272, use patent
patent.txt lines 16,836, 16,851- Flags
- use code U-3935
- Product numbers
- 001, 002
17 Jul 2040 · NDA 215390 · DEXMEDETOMIDINE HYDROCHLORIDE
US 11,998,529, use patent
patent.txt lines 16,838, 16,853- Flags
- use code U-3935
- Product numbers
- 001, 002
17 Jul 2040 · NDA 215390 · DEXMEDETOMIDINE HYDROCHLORIDE
US 12,109,196, use patent
patent.txt lines 16,840, 16,855- Flags
- use code U-3935
- Product numbers
- 001, 002
19 Jul 2040 · NDA 217593 · MELOXICAM
US 12,059,423, substance and product patent
patent.txt line 20,025- Flags
- substance product
- Product numbers
- 001
22 Jul 2040 · NDA 202860 · NITRIC OXIDE
US 11,672,938, use patent
patent.txt line 3,413- Flags
- use code U-3037
- Product numbers
- 001
27 Jul 2040 · NDA 216660 · SODIUM PHENYLBUTYRATE; TAURURSODIOL
US 11,583,542, product patent
patent.txt line 18,893- Flags
- product
- Product numbers
- 001
28 Jul 2040 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 12,233,067, use patent
patent.txt line 16,752- Flags
- use code U-4151
- Product numbers
- 001
31 Jul 2040 · NDA 216632 · ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
US 12,128,059, product and use patent
patent.txt line 18,878- Flags
- product use code U-3713
- Product numbers
- 001
31 Jul 2040 · NDA 216632 · ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
US 12,133,859, product patent
patent.txt line 18,879- Flags
- product
- Product numbers
- 001
31 Jul 2040 · NDA 216632 · ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
US 12,138,278, product patent
patent.txt line 18,880- Flags
- product
- Product numbers
- 001
31 Jul 2040 · NDA 216632 · ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
US 12,616,710, product patent
patent.txt line 18,881- Flags
- product
- Product numbers
- 001
3 Aug 2040 · NDA 217026 · TROFINETIDE
US 11,370,755, substance and product patent
patent.txt line 19,250- Flags
- substance product
- Product numbers
- 001
3 Aug 2040 · NDA 219884 · TROFINETIDE
US 11,370,755, substance and product patent
patent.txt lines 22,038, 22,046, 22,054- Flags
- substance product
- Product numbers
- 001, 002, 003
10 Aug 2040 · NDA 209241 · VALBENAZINE TOSYLATE
US 10,940,141, use patent
patent.txt lines 9,941, 9,974, 10,007- Flags
- use code U-1995
- Product numbers
- 001, 002, 003
10 Aug 2040 · NDA 218390 · VALBENAZINE TOSYLATE
US 10,940,141, use patent
patent.txt lines 20,999, 21,032, 21,065- Flags
- use code U-1995
- Product numbers
- 001, 002, 003
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 10,966,966, use patent
patent.txt line 15,352- Flags
- use code U-3153
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,266,635, use patent
patent.txt line 15,354- Flags
- use code U-3330
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,344,536, use patent
patent.txt line 15,355- Flags
- use code U-3381
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,426,390, use patent
patent.txt line 15,357- Flags
- use code U-3416
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,433,056, use patent
patent.txt line 15,358- Flags
- use code U-3423
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,529,336, use patent
patent.txt line 15,359- Flags
- use code U-3382
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,534,432, use patent
patent.txt line 15,360- Flags
- use code U-3442
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,576,904, use patent
patent.txt line 15,362- Flags
- use code U-3537
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 11,813,251, use patent
patent.txt line 15,367- Flags
- use code U-3750
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,023,325, use patent
patent.txt line 15,377- Flags
- use code U-3960
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,023,326, use patent
patent.txt line 15,378- Flags
- use code U-3959
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,023,327, use patent
patent.txt line 15,379- Flags
- use code U-3958
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,059,410, use patent
patent.txt line 15,381- Flags
- use code U-3153
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,059,411, use patent
patent.txt line 15,382- Flags
- use code U-3971
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,295,944, use patent
patent.txt line 15,387- Flags
- use code U-4183
- Product numbers
- 001
12 Aug 2040 · NDA 213973 · RIPRETINIB
US 12,318,373, use patent
patent.txt line 15,388- Flags
- use code U-4191
- Product numbers
- 001
13 Aug 2040 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US 11,873,300, substance and product and use patent
patent.txt lines 21,200, 21,246- Flags
- substance product use code U-4083
- Product numbers
- 001, 002
13 Aug 2040 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US 11,873,300, substance and product and use patent
patent.txt lines 21,201, 21,247- Flags
- substance product use code U-4462
- Product numbers
- 001, 002
18 Aug 2040 · NDA 214510 · BENZOYL PEROXIDE
US 11,426,378, use patent
patent.txt line 15,817- Flags
- use code U-3356
- Product numbers
- 001
19 Aug 2040 · NDA 219792 · DOXECITINE; DOXRIBTIMINE
US 11,649,259, product and use patent
patent.txt line 22,009- Flags
- product use code U-4358
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,433,046, use patent
patent.txt line 15,968- Flags
- use code U-3413
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,433,046, use patent
patent.txt line 15,969- Flags
- use code U-3414
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,433,046, use patent
patent.txt line 15,970- Flags
- use code U-3415
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,633,374, product patent
patent.txt line 15,971- Flags
- product
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,826,343, product patent
patent.txt line 15,972- Flags
- product
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,911,362, product and use patent
patent.txt line 15,973- Flags
- product use code U-3413
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,911,362, product and use patent
patent.txt line 15,974- Flags
- product use code U-3414
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 11,911,362, product and use patent
patent.txt line 15,975- Flags
- product use code U-3415
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 12,290,503, product and use patent
patent.txt line 15,976- Flags
- product use code U-3413
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 12,290,503, product and use patent
patent.txt line 15,977- Flags
- product use code U-3414
- Product numbers
- 001
21 Aug 2040 · NDA 214679 · TOPIRAMATE
US 12,290,503, product and use patent
patent.txt line 15,978- Flags
- product use code U-3415
- Product numbers
- 001
27 Aug 2040 · NDA 210450 · ELAGOLIX SODIUM
US 11,690,845, use patent
patent.txt lines 11,390, 11,398- Flags
- use code U-3654
- Product numbers
- 001, 002
27 Aug 2040 · NDA 213388 · ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM
US 11,690,845, use patent
patent.txt line 14,972- Flags
- use code U-3655
- Product numbers
- 001
30 Aug 2040 · NDA 213736 · PEMIGATINIB
US 11,628,162, use patent
patent.txt lines 15,228, 15,238, 15,248- Flags
- use code U-3568
- Product numbers
- 001, 002, 003
30 Aug 2040 · NDA 213736 · PEMIGATINIB
US 11,628,162, use patent
patent.txt lines 15,229, 15,239, 15,249- Flags
- use code U-3569
- Product numbers
- 001, 002, 003
30 Aug 2040 · NDA 213736 · PEMIGATINIB
US 11,628,162, use patent
patent.txt lines 15,230, 15,240, 15,250- Flags
- use code U-3570
- Product numbers
- 001, 002, 003
30 Aug 2040 · NDA 213736 · PEMIGATINIB
US 11,628,162, use patent
patent.txt lines 15,231, 15,241, 15,251- Flags
- use code U-3571
- Product numbers
- 001, 002, 003
30 Aug 2040 · NDA 219847 · LISDEXAMFETAMINE DIMESYLATE
US 11,576,878, product patent
patent.txt line 22,023- Flags
- product
- Product numbers
- 001
1 Sep 2040 · NDA 214044 · TRAMADOL HYDROCHLORIDE
US 11,103,452, product and use patent
patent.txt line 15,459- Flags
- product use code U-3197
- Product numbers
- 001
1 Sep 2040 · NDA 214044 · TRAMADOL HYDROCHLORIDE
US 11,752,103, product and use patent
patent.txt line 15,460- Flags
- product use code U-3197
- Product numbers
- 001
4 Sep 2040 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,510,923, use patent
patent.txt line 16,744- Flags
- use code U-3505
- Product numbers
- 001
4 Sep 2040 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 11,590,137, use patent
patent.txt line 16,748- Flags
- use code U-3505
- Product numbers
- 001
4 Sep 2040 · NDA 215309 · RUXOLITINIB PHOSPHATE
US 12,589,096, use patent
patent.txt line 16,755- Flags
- use code U-3505
- Product numbers
- 001
7 Sep 2040 · NDA 206229 · LEVONORGESTREL
US 11,571,328, product patent
patent.txt line 6,446- Flags
- product
- Product numbers
- 001
11 Sep 2040 · NDA 213586 · RISPERIDONE
US 12,128,132, product and use patent
patent.txt lines 15,088, 15,097, 15,106- Flags
- product use code U-601
- Product numbers
- 001, 002, 003
11 Sep 2040 · NDA 213586 · RISPERIDONE
US 12,128,132, product and use patent
patent.txt lines 15,087, 15,096, 15,105, 15,114, 15,120, 15,126, 15,132- Flags
- product use code U-543
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
11 Sep 2040 · NDA 213586 · RISPERIDONE
US 12,383,493, product and use patent
patent.txt lines 15,091, 15,100, 15,109- Flags
- product use code U-601
- Product numbers
- 001, 002, 003
11 Sep 2040 · NDA 213586 · RISPERIDONE
US 12,383,493, product and use patent
patent.txt lines 15,090, 15,099, 15,108, 15,116, 15,122, 15,128, 15,134- Flags
- product use code U-543
- Product numbers
- 001, 002, 003, 004, 005, 006, 007
11 Sep 2040 · NDA 219616 · AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE
US 11,517,573, use patent
patent.txt line 21,795- Flags
- use code U-4196
- Product numbers
- 001
11 Sep 2040 · NDA 219616 · AVUTOMETINIB POTASSIUM; DEFACTINIB HYDROCHLORIDE
US 11,517,573, use patent
patent.txt line 21,796- Flags
- use code U-4205
- Product numbers
- 001
15 Sep 2040 · NDA 214665 · SOTORASIB
US 11,426,404, use patent
patent.txt lines 15,941, 15,951, 15,961- Flags
- use code U-3306
- Product numbers
- 001, 002, 003
15 Sep 2040 · NDA 214665 · SOTORASIB
US 11,426,404, use patent
patent.txt lines 15,942, 15,952, 15,962- Flags
- use code U-4107
- Product numbers
- 001, 002, 003
18 Sep 2040 · NDA 214958 · DEUCRAVACITINIB
US 12,734,169, product and use patent
patent.txt line 16,386- Flags
- product use code U-3434
- Product numbers
- 001
18 Sep 2040 · NDA 214958 · DEUCRAVACITINIB
US 12,734,169, product and use patent
patent.txt line 16,387- Flags
- product use code U-4452
- Product numbers
- 001
1 Oct 2040 · NDA 212888 · CABOTEGRAVIR; RILPIVIRINE
US 12,636,285, use patent
patent.txt lines 14,482, 14,492- Flags
- use code U-3348
- Product numbers
- 001, 002
1 Oct 2040 · NDA 212888 · CABOTEGRAVIR; RILPIVIRINE
US 12,636,286, use patent
patent.txt lines 14,483, 14,493- Flags
- use code U-3348
- Product numbers
- 001, 002
3 Oct 2040 · NDA 213736 · PEMIGATINIB
US 12,552,792, substance and product patent
patent.txt lines 15,232, 15,242, 15,252- Flags
- substance product
- Product numbers
- 001, 002, 003
7 Oct 2040 · NDA 212576 · CEDAZURIDINE; DECITABINE
US 12,195,496, product patent
patent.txt line 14,174- Flags
- product
- Product numbers
- 001
13 Oct 2040 · NDA 219685 · RILZABRUTINIB
US 12,178,818, use patent
patent.txt line 21,865- Flags
- use code U-4267
- Product numbers
- 001
15 Oct 2040 · NDA 208081 · AMINOLEVULINIC ACID HYDROCHLORIDE
US 11,235,169, use patent
patent.txt line 8,108- Flags
- use code U-3303
- Product numbers
- 001
16 Oct 2040 · NDA 208088 · TESTOSTERONE UNDECANOATE
US 12,011,503, product and use patent
patent.txt line 8,215- Flags
- product use code U-3964
- Product numbers
- 001
16 Oct 2040 · NDA 208088 · TESTOSTERONE UNDECANOATE
US 12,011,503, product and use patent
patent.txt line 8,216- Flags
- product use code U-3965
- Product numbers
- 001
23 Oct 2040 · NDA 219122 · SITAGLIPTIN HYDROCHLORIDE
US 11,944,621, product patent
patent.txt line 21,499- Flags
- product
- Product numbers
- 001
23 Oct 2040 · NDA 219122 · SITAGLIPTIN HYDROCHLORIDE
US 12,295,953, product patent
patent.txt line 21,500- Flags
- product
- Product numbers
- 001
28 Oct 2040 · NDA 213312 · SIROLIMUS
US 11,497,737, product patent
patent.txt line 14,878- Flags
- product
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,052,196, use patent
patent.txt line 14,798- Flags
- use code U-4007
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,052,196, use patent
patent.txt line 14,799- Flags
- use code U-4008
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,052,196, use patent
patent.txt line 14,800- Flags
- use code U-4009
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,246,991, use patent
patent.txt line 14,801- Flags
- use code U-4007
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,246,991, use patent
patent.txt line 14,802- Flags
- use code U-4008
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,246,991, use patent
patent.txt line 14,803- Flags
- use code U-4009
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,534,553, use patent
patent.txt line 14,804- Flags
- use code U-4007
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,534,553, use patent
patent.txt line 14,805- Flags
- use code U-4008
- Product numbers
- 001
3 Nov 2040 · NDA 213224 · OCTREOTIDE ACETATE
US 11,534,553, use patent
patent.txt line 14,806- Flags
- use code U-4009
- Product numbers
- 001
3 Nov 2040 · NDA 216655 · ARIPIPRAZOLE
US 11,331,315, product patent
patent.txt lines 18,884, 18,886, 18,888- Flags
- product
- Product numbers
- 001, 002, 003
13 Nov 2040 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 12,168,666, substance and product patent
patent.txt line 15,642- Flags
- substance product
- Product numbers
- 001
22 Nov 2040 · NDA 220073 · APIXABAN
US 11,896,586, product and use patent
patent.txt line 22,088- Flags
- product use code U-4180
- Product numbers
- 001
25 Nov 2040 · NDA 220018 · LENACAPAVIR SODIUM
US 11,807,625, use patent
patent.txt line 22,081- Flags
- use code U-4190
- Product numbers
- 001
2 Dec 2040 · NDA 216873 · MOMELOTINIB DIHYDROCHLORIDE
US 11,963,962, use patent
patent.txt lines 19,024, 19,029, 19,034- Flags
- use code U-3928
- Product numbers
- 001, 002, 003
4 Dec 2040 · NDA 219209 · SUZETRIGINE
US 11,834,441, substance and product and use patent
patent.txt line 21,557- Flags
- substance product use code U-4125
- Product numbers
- 001
4 Dec 2040 · NDA 219500 · BUMETANIDE
US 11,123,319, product patent
patent.txt line 21,789- Flags
- product
- Product numbers
- 001
4 Dec 2040 · NDA 219500 · BUMETANIDE
US 11,260,038, use patent
patent.txt line 21,790- Flags
- use code U-4279
- Product numbers
- 001
4 Dec 2040 · NDA 219500 · BUMETANIDE
US 12,329,731, product and use patent
patent.txt line 21,791- Flags
- product use code U-4279
- Product numbers
- 001
10 Dec 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 11,753,419, product patent
patent.txt lines 10,442, 10,480, 10,511- Flags
- product delist requested
- Product numbers
- 001, 002, 003
10 Dec 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 12,122,792, product and use patent
patent.txt lines 10,452, 10,486, 10,517- Flags
- product use code U-4019
- Product numbers
- 001, 002, 003
10 Dec 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 12,122,792, product and use patent
patent.txt lines 10,453, 10,487, 10,518- Flags
- product use code U-4020
- Product numbers
- 001, 002, 003
10 Dec 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 12,122,792, product and use patent
patent.txt lines 10,454, 10,488, 10,519- Flags
- product use code U-4340
- Product numbers
- 001, 002, 003
10 Dec 2040 · NDA 209500 · LUMATEPERONE TOSYLATE
US 12,410,195, product patent
patent.txt lines 10,458, 10,490, 10,521- Flags
- product
- Product numbers
- 001, 002, 003
11 Dec 2040 · NDA 214517 · TASIMELTEON
US 11,202,770, product patent
patent.txt line 15,844- Flags
- product
- Product numbers
- 001
11 Dec 2040 · NDA 214517 · TASIMELTEON
US 12,447,141, use patent
patent.txt line 15,859- Flags
- use code U-3003
- Product numbers
- 001
16 Dec 2040 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 11,491,137, use patent
patent.txt line 21,548- Flags
- use code U-3980
- Product numbers
- 001
16 Dec 2040 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 11,998,526, use patent
patent.txt line 21,550- Flags
- use code U-3980
- Product numbers
- 001
16 Dec 2040 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 12,121,509, use patent
patent.txt line 21,551- Flags
- use code U-3980
- Product numbers
- 001
16 Dec 2040 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 12,370,174, use patent
patent.txt line 21,552- Flags
- use code U-3980
- Product numbers
- 001
27 Dec 2040 · NDA 214510 · BENZOYL PEROXIDE
US 11,628,155, use patent
patent.txt line 15,819- Flags
- use code U-3356
- Product numbers
- 001
27 Dec 2040 · NDA 214510 · BENZOYL PEROXIDE
US 12,295,935, use patent
patent.txt line 15,825- Flags
- use code U-3356
- Product numbers
- 001
27 Dec 2040 · NDA 214902 · BENZOYL PEROXIDE; TRETINOIN
US 12,295,935, use patent
patent.txt line 16,314- Flags
- use code U-3987
- Product numbers
- 001
28 Dec 2040 · NDA 208232 · OCTREOTIDE ACETATE
US 11,141,457, use patent
patent.txt line 8,360- Flags
- use code U-3232
- Product numbers
- 001
28 Dec 2040 · NDA 208232 · OCTREOTIDE ACETATE
US 11,890,316, use patent
patent.txt line 8,364- Flags
- use code U-3232
- Product numbers
- 001
28 Dec 2040 · NDA 216632 · ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
US 11,389,467, product and use patent
patent.txt line 18,877- Flags
- product use code U-3713
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,185,535, product patent
patent.txt line 15,353- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,395,818, product patent
patent.txt line 15,356- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,576,903, product patent
patent.txt line 15,361- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,612,591, product patent
patent.txt line 15,363- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,793,795, product patent
patent.txt line 15,365- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,801,237, product and use patent
patent.txt line 15,366- Flags
- product use code U-3219
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,844,788, product patent
patent.txt line 15,368- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,850,240, product patent
patent.txt line 15,369- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,850,241, product patent
patent.txt line 15,370- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,896,585, product patent
patent.txt line 15,371- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,903,933, product patent
patent.txt line 15,372- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,911,370, product patent
patent.txt line 15,373- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,918,564, product patent
patent.txt line 15,374- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 11,969,415, use patent
patent.txt line 15,376- Flags
- use code U-3219
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,023,328, use patent
patent.txt line 15,380- Flags
- use code U-3957
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,064,422, use patent
patent.txt line 15,383- Flags
- use code U-3219
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,213,967, product patent
patent.txt line 15,384- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,213,968, product patent
patent.txt line 15,385- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,226,406, product patent
patent.txt line 15,386- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,318,374, product patent
patent.txt line 15,389- Flags
- product
- Product numbers
- 001
30 Dec 2040 · NDA 213973 · RIPRETINIB
US 12,708,617, use patent
patent.txt line 15,390- Flags
- use code U-3219
- Product numbers
- 001
Pediatric exclusivity, as listed (2)
9 Sep 2040 · NDA 202293 · DAPAGLIFLOZIN
US 10,973,836 with pediatric exclusivity, as listed
patent.txt line 3,003- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 002
9 Sep 2040 · NDA 202293 · DAPAGLIFLOZIN
US 11,903,955 with pediatric exclusivity, as listed
patent.txt line 3,007- Flags
- pediatric, as listed by FDA (from the base row)
- Product numbers
- 002